KS

Kavita Singh

Active Director Director DIN 06784250
DIN 06784250 First appointment Feb 2014 Primary industry Travel and Hospitality
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 2 active board seats
Past companies 5 historical roles
Total affiliations 7 Since Feb 2014
Shareholding value β€’β€’β€’β€’ Premium profile

About Kavita Singh

Data last updated:

Kavita Singh is a Director at Foundation For Innovation And Social Entrepreneurship (since 2026) and Director at Immunoscript Life Science Private Limited (since 2026). The companies operate in Travel and Hospitality, Life Sciences and Pharma. The largest current company by reported revenue is Foundation For Innovation And Social Entrepreneurship at ₹52.67 Cr (FY 2025). Earlier, Kavita Singh was an Additional Director at Gennova Biopharmaceuticals Limited (2023) and Director at Drugs For Neglected Diseases Initiative South Asia Private Limited (2023–2025) and 3 more.

DIN 06784250
Primary Designation Director
Industry Travel and Hospitality
First Appointment 05 Feb 2014
Oldest Company Age 11 yrs
Largest company Foundation For Innovation And Social Entrepreneurship Β· ₹52.67 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director11 May 20262015₹52.67 Cr (FY 2025)Active
Director28 Apr 20262026Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Gennova Biopharmaceuticals Limited U24231PN2001PLC016253
Additional Director24 Jan 20232001₹376 Cr (FY 2023)Active
Director15 Sep 20232023Active
Veeda Clinical Research Limited U73100GJ2004PLC044023
Director01 Jul 20212004₹621 Cr (FY 2025)Active
Director13 Dec 20172017Strike Off
Sakosh Biotech Private Limited U73200UP2014PTC062485
Director05 Feb 20142014₹22.8 Lakh (FY 2017)Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Immunoscript Life Science Private Limited
Foundation For Innovation And Social Entrepreneurship
Gennova Biopharmaceuticals Limited
Drugs For Neglected Diseases Initiative South Asia Private Limited
Premium access

Shareholding and investment profile for Kavita Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kavita Singh

Kavita Singh currently holds 2 directorships: Foundation For Innovation And Social Entrepreneurship (Director, since 11 May 2026, revenue β‚Ή52.67 Cr (FY 2025)); Immunoscript Life Science Private Limited (Director, since 28 Apr 2026).

Kavita Singh was first appointed on 05 Feb 2014 as Director at Sakosh Biotech Private Limited. The most recent appointment on record is 11 May 2026 at Foundation For Innovation And Social Entrepreneurship.

Kavita Singh held 5 earlier board appointments: Gennova Biopharmaceuticals Limited (Additional Director, 24 Jan 2023 to 09 Jul 2023); Drugs For Neglected Diseases Initiative South Asia Private Limited (Director, 15 Sep 2023 to 16 Dec 2025); Veeda Clinical Research Limited (Director, 01 Jul 2021 to 31 Dec 2023); Rcupe Health Technologies Private Limited (Director, 13 Dec 2017 to 10 Mar 2018); Sakosh Biotech Private Limited (Director, 05 Feb 2014 to 10 Mar 2018).

The current boards of Kavita Singh's companies include Ganesh Satish Neelam (Foundation For Innovation And Social Entrepreneurship), Manoj Kumar (Foundation For Innovation And Social Entrepreneurship), Neeraj Jain (Foundation For Innovation And Social Entrepreneurship), Sanjay Singh (Immunoscript Life Science Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available